A detailed history of Bluestein R H & CO LLC transactions in Danaher Corp stock. As of the latest transaction made, Bluestein R H & CO LLC holds 3,888 shares of DHR stock, worth $916,945. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,888
Previous 2,880 35.0%
Holding current value
$916,945
Previous $730,000 37.53%
% of portfolio
0.06%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $249,036 - $1.52 Million
1,008 Added 35.0%
3,888 $1 Million
Q2 2022

Aug 11, 2022

BUY
$237.11 - $299.66 $118,555 - $149,830
500 Added 21.01%
2,880 $730,000
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $128,634 - $157,880
-500 Reduced 17.36%
2,380 $698,000
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $68,052 - $83,107
-250 Reduced 7.99%
2,880 $877,000
Q1 2021

May 12, 2021

SELL
$212.38 - $245.9 $254,856 - $295,080
-1,200 Reduced 27.71%
3,130 $705,000
Q4 2020

Feb 12, 2021

SELL
$212.5 - $245.46 $106,250 - $122,730
-500 Reduced 10.35%
4,330 $962,000
Q2 2020

Aug 12, 2020

BUY
$128.7 - $176.83 $218,789 - $300,611
1,700 Added 54.31%
4,830 $854,000
Q1 2020

May 12, 2020

SELL
$121.39 - $169.05 $60,695 - $84,525
-500 Reduced 13.77%
3,130 $433,000
Q4 2019

Feb 13, 2020

BUY
$133.47 - $153.48 $86,755 - $99,762
650 Added 21.81%
3,630 $557,000
Q3 2019

Nov 13, 2019

SELL
$135.4 - $146.47 $36,558 - $39,546
-270 Reduced 8.31%
2,980 $430,000
Q2 2019

Aug 12, 2019

SELL
$124.88 - $143.73 $93,660 - $107,797
-750 Reduced 18.75%
3,250 $464,000
Q1 2019

May 10, 2019

BUY
$97.62 - $132.29 $146,430 - $198,435
1,500 Added 60.0%
4,000 $528,000
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $198,225 - $221,125
2,500
2,500 $214,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bluestein R H & CO LLC Portfolio

Follow Bluestein R H & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.